Literature DB >> 12909477

Progressive multifocal leukoencephalopathy in a lung transplant recipient.

David Shitrit1, Lev Nirit, Sheely I Shiran, Gabriel Izbicki, Dov Sofer, Melamed Eldad, Mordechai R Kramer.   

Abstract

Progressive multifocal leukoencephalopathy (PML) is a sub-acute, demyelinating disease of the brain caused by a human polyomavirus. We describe a patient with the onset of PML 7 months after lung transplantation. The patient was treated with immunosuppressive modulation and cidofovir, a new anti-viral therapy for PML, with stabilization of the symptoms. We also review the 4 additional reports in the literature of PML after heart and lung transplantation. Progressive multifocal leukoencephalopathy may become more prevalent as the population of heart and lung transplantation recipients increases.

Entities:  

Mesh:

Year:  2003        PMID: 12909477     DOI: 10.1016/s1053-2498(02)00804-5

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  7 in total

1.  Progressive multifocal leukoencephalopathy in transplant recipients.

Authors:  Farrah J Mateen; RajaNandini Muralidharan; Marco Carone; Diederik van de Beek; Daniel M Harrison; Allen J Aksamit; Mary S Gould; David B Clifford; Avindra Nath
Journal:  Ann Neurol       Date:  2011-08       Impact factor: 10.422

2.  High frequency and diversity of rearrangements in polyomavirus bk noncoding regulatory regions cloned from urine and plasma of Israeli renal transplant patients and evidence for a new genetic subtype.

Authors:  Tsachi Tsadok Perets; Ilana Silberstein; Jana Rubinov; Ronit Sarid; Ella Mendelson; Lester M Shulman
Journal:  J Clin Microbiol       Date:  2009-03-04       Impact factor: 5.948

3.  Progressive multifocal leukoencephalopathy following heightened immunosuppression after lung transplant.

Authors:  Jesse Waggoner; Tereza Martinu; Scott M Palmer
Journal:  J Heart Lung Transplant       Date:  2009-04       Impact factor: 10.247

4.  Identification and characterization of mefloquine efficacy against JC virus in vitro.

Authors:  Margot Brickelmaier; Alexey Lugovskoy; Ramya Kartikeyan; Marta M Reviriego-Mendoza; Norm Allaire; Kenneth Simon; Richard J Frisque; Leonid Gorelik
Journal:  Antimicrob Agents Chemother       Date:  2009-03-02       Impact factor: 5.191

5.  Progressive Multifocal Leukoencephalopathy in a Lung Transplant Recipient: Isolation of John Cunningham (JC) Virus from Bronchoalveolar Lavage.

Authors:  Tanmay S Panchabhai; Chirag Choudhary; Carlos Isada; Erik Folch; Atul C Mehta
Journal:  J Glob Infect Dis       Date:  2016 Jan-Mar

6.  Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases.

Authors:  Roderick P P W M Maas; Annemarie H G Muller-Hansma; Rianne A J Esselink; Jean-Luc Murk; Clemens Warnke; Joep Killestein; Mike P Wattjes
Journal:  J Neurol       Date:  2016-07-11       Impact factor: 4.849

Review 7.  Probable progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with immunosuppressant dose reduction following lung transplantation: a case report and literature review.

Authors:  Kazuhiro Ishii; Fumiko Yamamoto; Shinsuke Homma; Yoshinori Okada; Kazuo Nakamichi; Masayuki Saijo; Akira Tamaoka
Journal:  BMC Neurol       Date:  2019-10-31       Impact factor: 2.474

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.